Enteric solid oral dosage form of bisphosphonate containing a chelating agent

Details for Australian Patent Application No. 2005247299 (hide)

Owner The Procter & Gamble Company

Inventors Burgio, David, Ernest, Jr.; Dansereau, Richard, John

Agent Pizzeys

Pub. Number AU-B-2005247299

PCT Pub. Number WO2005/115331

Priority 60/573,881 24.05.04 US

Filing date 14 April 2005

Wipo publication date 8 December 2005

Acceptance publication date 15 May 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/115331 Priority application(s): WO2005/115331

15 May 2008 Application Accepted

  Published as AU-B-2005247299

11 September 2008 Standard Patent Sealed

25 February 2010 Assignment Registered

  The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247301-FCγRIIB-specific antibodies and methods of use thereof

2005247298-Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases